Novel topical formulation demonstrates potential in peripheral neuropathy

A topical formulation of an existing neurocosmetic drug available in the EU could offer a “targeted and safer alternative” for chemotherapy-induced peripheral neuropathy (CIPN), according to researchers in Spain